[NKTR] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -129.56%
YoY- -51.58%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 23,885 24,144 20,499 21,594 22,023 23,625 21,585 6.96%
PBT -42,108 -45,898 -51,169 -137,081 -56,544 -59,204 -158,968 -58.65%
Tax -29 -61 -47 -63 3,144 -155 100 -
NP -42,079 -45,837 -51,122 -137,018 -59,688 -59,049 -159,068 -58.69%
Tax Rate - - - - - - - -
Total Cost 65,964 69,981 71,621 158,612 81,711 82,674 180,653 -48.81%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -176.17 -189.85 -249.39 -634.52 -271.03 -249.94 -736.94 -61.38%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.22 -0.24 -0.27 -0.73 -0.32 -0.31 -0.85 -59.28%
EPS Diluted -0.22 -0.24 -0.27 -0.73 -0.32 -0.31 -0.85 -59.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.